Page 36 - Škrgat, Sabina, ed. 2022. Severe Asthma - Basic and Clinical Views. Koper: University of Primorska Press. Severe Asthma Forum, 1
P. 36
65. Bousquet J, Boulet LP, Peters MJ, et
al. Budesonide/formoterol for mainte-
severe asthma forum 1: severe asthma - basic and clinical views nance and relief in uncontrolled asth-
ma vs. high-dose salmeterol/fluticasone.
Respir Med. 2007 Dec;101(12):2437-
46.

66. Global Initiative for Asthma. Archived
reports [Internet]. [place unknown]:
Global Initiative for Asthma; 2022.
Available from: https://ginasthma.org/
archived-reports/.

67. Global Initiative for Asthma. Global
Strategy for Asthma Management and
Prevention [Internet]. [place unknown]:
Global Initiative for Asthma, 2018.
Available from: https://ginasthma.org/.

68. Royal College of Physicians. Why asth-
ma still kills: The National Review of
Asthma Deaths (NRAD). London:
Royal College of Physicians; 2014.
(Confidential enquiry report).

69. O’Byrne PM, Jenkins C, Bateman ED.
The paradoxes of asthma manage-
ment: time for a new approach? Eur
Respir J. 2017 Sep 9;50(3):1701103. doi:
10.1183/13993003.01103-2017.

70. O’Byrne PM, FitzGerald JM, Bateman
ED, et al. Inhaled Combined Budes-
onide–Formoterol as Needed in Mild
Asthma. N Engl J Med. 2018 May
17;378(20):1865-76.

71. Bateman ED, Reddel HK, O’Byrne
PM, et al. As-Needed Budesonide–For-
moterol versus Maintenance Budeso-
nide in Mild Asthma. N Engl J Med.
2018 May 17;378(20):1877-87.

72. Global Initiative for Asthma. Global
Strategy for Asthma Management and
Prevention [Internet]. [place unknown]:
Global Initiative for Asthma, c2019.
Available from: https://ginasthma.org/.
   31   32   33   34   35   36   37   38   39   40   41